Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: a pharmaceutical industry perspective.
Boccuzzi
S J
SJ
Outcomes Research and Management, Merck and Co, West Poin, PA 19486, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D004345:Drug Industry / Q000191:economics* / Q000639:trends; D017850:Economics, Pharmaceutical; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D006333:Heart Failure / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D014481:United States
D000806:Angiotensin-Converting Enzyme Inhibitors